Short Interest in BioRestorative Therapies, Inc. (NASDAQ:BRTX) Increases By 19.4%

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 130,200 shares, a growth of 19.4% from the December 31st total of 109,000 shares. Approximately 2.6% of the shares of the stock are short sold. Based on an average trading volume of 64,600 shares, the days-to-cover ratio is presently 2.0 days.

BioRestorative Therapies Trading Down 0.8 %

NASDAQ BRTX traded down $0.02 during trading hours on Monday, reaching $2.36. 66,042 shares of the company’s stock were exchanged, compared to its average volume of 72,621. The firm has a fifty day moving average of $1.70 and a 200-day moving average of $1.63. BioRestorative Therapies has a one year low of $1.03 and a one year high of $3.67. The stock has a market cap of $16.33 million, a PE ratio of -1.54 and a beta of 62.64.

BioRestorative Therapies (NASDAQ:BRTX) last announced its earnings results on Tuesday, November 12th. The company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.22. The company had revenue of $0.23 million during the quarter, compared to analyst estimates of $0.30 million. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. As a group, research analysts forecast that BioRestorative Therapies will post -1.43 EPS for the current year.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.